Are Smokers Switching to Vaping at Lower Risk for Cancer? (Electronic Cigarettes and Cancer Risk) (NCT03750825)
Are Smokers Switching to Vaping at Lower Risk for Cancer?
๐ฉบ Plain-English Summary (8th-Grade Level)
This project will address a growing public health concern, namely, the health risks or benefits of e-cig use relative to cigarette smoking. The investigators will use biomarkers of early effects of relevance to cancer to determine the carcinogenic potential of e-cig use relative to cigarette smoking in oral epithelium, which is a target tissue for smoking-associated cancer. The study population will consist of one group of smokers who are interested in switching to e-cig use (Grp 1), one group of smokers who do not intend to change their smoking habits (Grp 2), and one group of non-users who would like to maintain their nonsmoking non-vaping status (Grp 3); The total number of participants in this project is 150 (n = 50, each group). The investigators will use an integrative 'multi-omics' approach complemented with single-locus/gene validation analyses to detect temporal changes in the genome, epigenome, and transcriptome relevant to cancer in the oral cells of the participants as the intervention progresses.
Who can join: Review the eligibility criteria below.
Location: University of Southern California, Health Sciences Campus โ Los Angeles, California
Age range: 22 Years to 55 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- University of Southern California, Health Sciences Campus โ Los Angeles, California
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cigarette Smoking
- Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit โ Philadelphia, Pennsylvania
- Evaluation of Low and High Nicotine Tobacco Free Nicotine Pouches โ Charleston, South Carolina
- A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse โ Charleston, South Carolina
- Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing โ Buffalo, New York
- Switch or Quit R01 โ Charleston, South Carolina
Explore by condition: All Cigarette Smoking clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.